Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience

To examine the outcome of patients diagnosed with 'low-risk' prostate cancer managed by active surveillance (AS).In all, 157 men with localized prostate cancer were followed on AS. The inclusion criteria for AS included: Gleason score of < or = 6, a serum prostate-specific antigen (PSA) level of < or = 15 ng/mL, stage < or = T2, low-volume disease and > 12 months of follow-up. The follow-up was rigorous, with PSA tests and a digital rectal...